We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

1 hedge funds and large institutions have $0 invested in Arena Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 312 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 316 → 1 (-315)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $4.86B → $0 (-$4.86B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 312

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-315
Holders Change %
-99.68%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
312
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$530M
2
BlackRock
BlackRock
New York
-$452M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$361M
4
State Street
State Street
Massachusetts
-$213M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$167M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCA
301
Stonebridge Capital Advisors
Minnesota
– -$5K -50 Closed
WT
302
Washington Trust
Rhode Island
– -$5K -50 Closed
TFS
303
TrustCore Financial Services
Tennessee
– -$3K -30 Closed
AWA
304
Amplius Wealth Advisors
Pennsylvania
– -$2K -22 Closed
FHA
305
First Horizon Advisors
Tennessee
– -$1K -18 Closed
GWS
306
Glassman Wealth Services
Virginia
– -$1K -16 Closed
AWM
307
Avior Wealth Management
Nebraska
– -$1K -12 Closed
C
308
Covestor
United Kingdom
– -$1K -10 Closed
MPWT
309
MassMutual Private Wealth & Trust
Connecticut
– -$1K -7 Closed
PP
310
PFS Partners
New Jersey
– -$465 -5 Closed
9 10 11 12
13

ARNA Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2022, worth a combined $0 — down 100% from $4.86B a quarter earlier.

Sellers outnumbered buyers: 312 funds closed out of ARNA and 0 opened new positions — a net loss of 312 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $530M sold.

  • 1 institutional investor held Arena Pharmaceuticals Inc (ARNA) as of Q1 2022, down from 316 in Q4 2021.
  • Funds reported $0 of Arena Pharmaceuticals Inc stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Arena Pharmaceuticals Inc positions in Q1 2022 and 312 closed out, a net change of -312 holders.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2022 was Vanguard Group, an estimated $530M sold.

Based on aggregated 13F filings for Q1 2022.